Találati lista | Tudóstér

001-es BibID:	BIBFORM079829
035-os BibID:	(cikkazonosító)AS05-056
Első szerző:	Fekete Klára (neurológus)
Cím:	Predictors of long-term outcome in patients with basilar artery occlusion : a single center study / K. Fekete, J. Toth, H. Mate, M. Sandor, H. Toth, L. Csiba, I. Fekete
Dátum:	2019
Megjegyzések:	Background and Aims: Basilar artery occlusion (BAO) is a fatal disease despite recanalization techniques and limited data is available of the factors predicting outcome. Methods: Data of 100 patients treated with BAO was collected prospectively between 2004 and 2018. Risk factors, neurological status, outcome (case fatality, 3-months-mRS, one-year-survival); cranial CT (posterior circulation ASPECT score), result of CT angiography; and the treatment modality was given. Results: Average age was 64.9 13.7 years, 54% male. The most remarkable risk factor was previous stroke (29%), 55% of it vertebrobasilar (58% mortality). The onset to treatment time was 4.23 2.85 hours. The pc-ASPECT score was 10 in 67%, 7 points 33%. BAO was in the proximal part in 17%, in half in 20%, total in 21% and only the top in 42%; respectively within its group the mortality was 53%, 45%, 62%, 38%. Intravenous thrombolysis happened in 43%, intraarterial in 27%, combined therapy in 18% and 12% was treated conservatively. Case fatality within the treatment group was respectively: 48.8%, 55.5%, 33.3%, and 66.6% (p ? 0.8). Symptomatic haemorrhage was not different among the recanalization groups (p ? 0.83). Total or partial recanalization was achieved in 39%. There was a favourable trend in the recanalization rate of intraarterial and combined groups (p ? 0.4). At 3 months 23% had mRS 0?2, 3?5 42%, 58% were dead. At one year 26% was alive. Conclusions: The top occlusion of the BA, combined therapy may influence favourably the outcome. Among the risk factors previous VB stroke has a high impact. Trial registration number: N/A
Tárgyszavak:	Orvostudományok Klinikai orvostudományok idézhető absztrakt haemorrhage
Megjelenés:	European Stroke Journal. - 4 : Suppl. 1 (2019), p. 740. -
További szerzők:	Tóth Judit (1964-) (radiológus) Máté H. Sándor Mária (1979-) (etnográfus) Tóth H. Csiba László (1952-) (neurológus, pszichiáter) Fekete István (1951-) (neurológus, pszichiáter)
Internet cím:	Intézményi repozitóriumban (DEA) tárolt változat
Borító:
Saját polcon:

001-es BibID:	BIBFORM079828
035-os BibID:	(cikkazonosító)AS24-058
Első szerző:	Szegedi István (orvos)
Cím:	The association of plasminogen activator inhibitor-1 (pai-1) 4g/5g polymorphism with the risk and prognosis of intracerebral hemorrhage / I. Szegedi, T. Arokszallasi, I. Fekete, K. Fekete, A. Nagy, F. Sarkady, E. G. Székely, K. R. Czuriga-Kovacs, E. Berenyi, Z. Bagoly, L. Csiba
Dátum:	2019
Megjegyzések:	Background and Aims: Non-traumatic intracerebral hemorrhage accounts for 10?15% of all strokes, but has much higher mortality than acute ischemic stroke (AIS). Plasminogen activator inhibitor-1 (PAI-1) is a natural inhibitor of fibrinolysis that protects against bleeding. PAI-1 5G/ 5G genotype is associated with lower PAI-1 levels, thus we hypothesized that it could be associated with the risk and outcome of intracerebral hemorrhage. Methods: Three populations were included in the study: 51 patients with primary intracerebral haemorrhage (PICH), 13 patients with AIS who suffered hemorrhagic transformation after intravenous thrombolysis (AIS-ICH), and 118 AIS patients without hemorrhagic events (AIS). PAI-1 4G/5G polymorphism was determined in all patients. Clinical data was registered on admission and day 7 post-event. Short-term outcome was defined according to NIHSS change at 7 days. Long-term outcome was measured by the modified Rankin Scale at 3 months. Results: The presence of PAI-1 5G allele was significantly more frequent in the AIS-ICH group as compared to the AIS and PICH cohorts and a population control cohort. PAI-1 4G/5G polymorphism had no effect on stroke severity or short-term outcome in either groups. In a binary backward logistic regression model including age, gender, BMI, NIHSS on admission, hypertension, hyperlipidaemia it was revealed that PAI-1 5G/5G genotype confers an independent, significant risk for post-lysis intracranial hemorrhage (OR:4.75, 95%CI:1.18-19.06, p ? 0.028). PAI-1 4G/5G polymorphism had no influence on mortality and long-term outcome in the studied patient cohorts. Conclusions: PAI-1 5G/5G genotype confers an independent, significant risk for post-lysis intracerebral haemorrhage.
Tárgyszavak:	Orvostudományok Klinikai orvostudományok idézhető absztrakt haemorrhage
Megjelenés:	European Stroke Journal. - 4 : Suppl. 1 (2019), p. 470. -
További szerzők:	Árokszállási Tamás (1988-) (neurológus) Fekete István (1951-) (neurológus, pszichiáter) Fekete Klára (1978-) (neurológus) Nagy A. Sarkady Ferenc (1982-) (laboratóriumi analitikus) Székely Edina Gabriella Czuriga-Kovács Katalin Réka (1981-) (neurológus) Berényi Ervin (1964-) (radiológus) Bagoly Zsuzsa (1978-) (orvos) Csiba László (1952-) (neurológus, pszichiáter)
Pályázati támogatás:	GINOP-2.3.2-15-2016-00043 GINOP NKFI-K120042 NKFI
Internet cím:	Intézményi repozitóriumban (DEA) tárolt változat
Borító:
Saját polcon: